More specifically, an evaluation of several histone PTMs, including acetylation marks from patient tumors, suggested that H3K9ac is associated with TNBC and HER2-positive breast tumors, whereas H3K27me3 correlates with the luminal A and B molecular subtypes [69]. Here, ERBB2 is linked to breast neoplasm.